Iguchi Kimi - Jan 9, 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
CFO & Treasurer
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Kimi Iguchi
Stock symbol
SAGE
Transactions as of
Jan 9, 2023
Transactions value $
$2,176
Form type
4
Date filed
1/11/2023, 03:02 PM
Previous filing
Jan 5, 2023
Next filing
Feb 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Options Exercise $2.18K +1.6K +2.76% $1.36* 59.6K Jan 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAGE Stock Option (Right to Buy) Options Exercise $0 -1.6K -22.09% $0.00 5.64K Jan 9, 2023 Common Stock 1.6K $1.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.